Objectives: To investigate the effect of pregabalin on erectile function and on the penile expression of nitric oxide synthase (NOS) isoforms in diabetic rat models. Methods: Male Sprague-Dawley rats were injected with streptozotocin to induce diabetes mellitus. The rats with blood glucose levels above 300 mg/dL were selected for the study. Those were randomly divided into 2 groups (N=10 per group): i) EDDM (erectile dysfunction diabetes mellitus)group fed with saline and ii) EDDM+Pregabalin treated group receiving pregabalin (10 mg/k/day) by intragastric administration. 10 animals served as a control group and received no streptozotocin. 4 weeks later, the erectile function of the rats was assessed by recording frequency of erection after subcutaneous apomorphine (80 ug/kg) injection. Superoxide anion generation and the expression of mRNA of nNOS and eNOS were evaluated in corpora cavernosum tissue. Results: Penile erection, the expression of both nNOS, eNOS and superoxide generation were significantly decreased in pregabalin treated group compared to control group. Conclusion: Treatment with pregabalin for 4 weeks decreases superoxide production but cannot improve erectile dysfunction in diabetic rats probably by inhibiting Ca 2+ channel-mediated NOS activation. © J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York.
CITATION STYLE
Amany, S., & Heba, K. (2013). Effect of pregabalin on erectile function and penile NOS expression in rats with streptozotocin-induced diabetes. Experimental and Clinical Endocrinology and Diabetes, 121(4), 230–233. https://doi.org/10.1055/s-0033-1341428
Mendeley helps you to discover research relevant for your work.